ASIS for Botox in Chronic Migraine

Clinical trial NCT02074163 · UNKNOWN

Trial details

NCT number: NCT02074163
Sponsor: ASIS Corporation
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Migraine More than15 Days Per Month, and Lasting 4 Hours a Day or Longer.

Start date: 2016-01-01
Primary completion: 2016-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.